Neck pain
Conditions
Interventions
Randomized controlled clinical trial, double blinded, with two arms, where the participants will be randomized into blocks with a 1:1 allocation ratio, through assignment provided by sealed opaque env
L01.224.160.875
Sponsors
Universidade Regional de Blumenau
Universidade Regional de Blumenau
Eligibility
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: History of persistent pain in the cervical region, delimited posteriorly by the superior nuchal line to the spine of the scapula and laterally to the superior border of the clavicle and the sternal notch, presenting or non-irradiation to the head, trunk and upper limbs, for at least three months; score of 3 or more points on the Numerical Pain Scale (END) during movement; Cervical Disability Index (NDI) equal to or greater than 20%, that is, 10 points.
Exclusion criteria
Exclusion criteria: History of previous rheumatic diseases, infectious or inflammatory diseases, tumors, cervical myelopathy, vertebrobasilar insufficiency and central or peripheral neurological disorders; history of trauma, fracture, or major surgery in the cervical, thoracic, or upper limbs; signs of nerve root compression such as decreased sensitivity of upper limb dermatomes, significant muscle weakness in upper limbs, decrease, abolition or increase in biceps and triceps reflexes; pregnancy; visual deficit without adequate correction; history of motion sickness, nausea, dizziness, vertigo and/or syncope without and with the use of the virtual reality device.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Kinesiophobia will be measured by applying the Tampa Scale for Kinesiophobia - TSK. It is expected to find a minimal clinically important difference of at least 15% reduction in scores compared to the control group, right after the intervention. ;Range of motion will be evaluated using a universal goniometer. It is expected to find a minimally important clinical difference of at least 5° in relation to the control group, right after the intervention. | — |
Primary
| Measure | Time frame |
|---|---|
| Pain intensity, assessed at rest and during movement, will be measured using the Numerical Pain Scale - NPS. It is expected to find a minimal clinically important difference of at least 1.5 points on the pain scale in relation to the control group, right after the intervention. | — |
Countries
Brazil
Contacts
Public ContactMarcelo Bracht
Universidade Regional de Blumenau
Outcome results
None listed